These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 24300991)

  • 1. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer.
    Heidari Z; Sariri R; Salouti M
    J Photochem Photobiol B; 2014 Jan; 130():40-6. PubMed ID: 24300991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer photothermal therapy based on gold nanorods targeted by covalently-coupled bombesin peptide.
    Heidari Z; Salouti M; Sariri R
    Nanotechnology; 2015 May; 26(19):195101. PubMed ID: 25900323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and characterization of Bombesin-superparamagnetic iron oxide nanoparticles as a targeted contrast agent for imaging of breast cancer using MRI.
    Jafari A; Salouti M; Shayesteh SF; Heidari Z; Rajabi AB; Boustani K; Nahardani A
    Nanotechnology; 2015 Feb; 26(7):075101. PubMed ID: 25642737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
    Ma L; Yu P; Veerendra B; Rold TL; Retzloff L; Prasanphanich A; Sieckman G; Hoffman TJ; Volkert WA; Smith CJ
    Mol Imaging; 2007; 6(3):171-80. PubMed ID: 17532883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PEGylation of (99m)Tc-labeled bombesin analogues improves their pharmacokinetic properties.
    Däpp S; García Garayoa E; Maes V; Brans L; Tourwé DA; Müller C; Schibli R
    Nucl Med Biol; 2011 Oct; 38(7):997-1009. PubMed ID: 21982571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin functionalized gold nanoparticles show in vitro and in vivo cancer receptor specificity.
    Chanda N; Kattumuri V; Shukla R; Zambre A; Katti K; Upendran A; Kulkarni RR; Kan P; Fent GM; Casteel SW; Smith CJ; Boote E; Robertson JD; Cutler C; Lever JR; Katti KV; Kannan R
    Proc Natl Acad Sci U S A; 2010 May; 107(19):8760-5. PubMed ID: 20410458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrin-releasing peptide receptor-targeted gadolinium oxide-based multifunctional nanoparticles for dual magnetic resonance/fluorescent molecular imaging of prostate cancer.
    Cui D; Lu X; Yan C; Liu X; Hou M; Xia Q; Xu Y; Liu R
    Int J Nanomedicine; 2017; 12():6787-6797. PubMed ID: 28979118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gastrin releasing protein receptor specific gold nanorods: breast and prostate tumor avid nanovectors for molecular imaging.
    Chanda N; Shukla R; Katti KV; Kannan R
    Nano Lett; 2009 May; 9(5):1798-805. PubMed ID: 19351145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrow band imaging of squamous cell carcinoma tumors using topically delivered anti-EGFR antibody conjugated gold nanorods.
    Puvanakrishnan P; Diagaradjane P; Kazmi SM; Dunn AK; Krishnan S; Tunnell JW
    Lasers Surg Med; 2012 Apr; 44(4):310-7. PubMed ID: 22415634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
    Smith CJ; Sieckman GL; Owen NK; Hayes DL; Mazuru DG; Volkert WA; Hoffman TJ
    Anticancer Res; 2003; 23(1A):63-70. PubMed ID: 12680195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Near-infrared fluorescence imaging of gastrin releasing peptide receptor targeting in prostate cancer lymph node metastases.
    Cai QY; Yu P; Besch-Williford C; Smith CJ; Sieckman GL; Hoffman TJ; Ma L
    Prostate; 2013 Jun; 73(8):842-54. PubMed ID: 23280511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation, in vitro and in vivo evaluation of (99m)Tc-N2S2-Tat(49-57)-bombesin: a target-specific hybrid radiopharmaceutical.
    Santos-Cuevas CL; Ferro-Flores G; Arteaga de Murphy C; Ramírez Fde M; Luna-Gutiérrez MA; Pedraza-López M; García-Becerra R; Ordaz-Rosado D
    Int J Pharm; 2009 Jun; 375(1-2):75-83. PubMed ID: 19393305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BBN conjugated GNPs: a new targeting contrast agent for imaging of breast cancer in radiology.
    Salouti M; Saghatchi F
    IET Nanobiotechnol; 2017 Aug; 11(5):604-611. PubMed ID: 28745296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary studies of
    Lahooti A; Shanehsazzadeh S; Laurent S
    Nanotechnology; 2020 Jan; 31(1):015102. PubMed ID: 31519003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
    Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B
    Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo application of radiolabeled gastrin-releasing peptide receptor ligands in breast cancer.
    Dalm SU; Martens JW; Sieuwerts AM; van Deurzen CH; Koelewijn SJ; de Blois E; Maina T; Nock BA; Brunel L; Fehrentz JA; Martinez J; de Jong M; Melis M
    J Nucl Med; 2015 May; 56(5):752-7. PubMed ID: 25791989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of bombesin peptide derivatives as potential tumor imaging agents: effects of structure and composition of amino acid sequence on in vitro and in vivo characteristics.
    Okarvi SM; Jammaz IA
    Nucl Med Biol; 2012 Aug; 39(6):795-804. PubMed ID: 22381782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vivo Tumor detection using diffusion reflection measurements of targeted gold nanorods - a quantitative study.
    Ankri R; Duadi H; Motiei M; Fixler D
    J Biophotonics; 2012 Mar; 5(3):263-73. PubMed ID: 22234916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insights into the Cellular Uptake, Cytotoxicity, and Cellular Death Modality of Phospholipid-Coated Gold Nanorods toward Breast Cancer Cell Lines.
    Mahmoud NN; Abu-Dahab R; Hamadneh LA; Abuarqoub D; Jafar H; Khalil EA
    Mol Pharm; 2019 Oct; 16(10):4149-4164. PubMed ID: 31398052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.